CTT PHARMACEUTICAL HOLDINGS, INC. - FORM 10-K - EX-23.1 - CONSENT OF AUDITORS - April 14, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CTT PHARMACEUTICAL HOLDINGS, INC.Financial_Report.xls
10-K - ANNUAL REPORT - CTT PHARMACEUTICAL HOLDINGS, INC.mdst_10k.htm
EX-31.1 - OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT - CTT PHARMACEUTICAL HOLDINGS, INC.mdst_ex31z1.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED - CTT PHARMACEUTICAL HOLDINGS, INC.mdst_ex32z2.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED - CTT PHARMACEUTICAL HOLDINGS, INC.mdst_ex32z1.htm
EX-31.2 - OFFICER'S CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT - CTT PHARMACEUTICAL HOLDINGS, INC.mdst_ex31z2.htm
EX-21 - SUBSIDIARIES OF REGISTRANT - CTT PHARMACEUTICAL HOLDINGS, INC.mdst_ex21.htm

EXHIBIT 23.1



[mdst_ex23z1002.gif]





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We have issued our Auditors’ report, dated April 10, 2015 accompanying the audited consolidated financial statements for the years ended December 31, 2014 and 2013 of Mindesta, Inc. We hereby consent to the incorporation of such report in this form 10-K Mindesta, Inc. for the year ended December 31, 2014.



[mdst_ex23z1003.jpg]


Vancouver, Canada

MNP LLP, Chartered Accountants

April 14, 2015











Stock widget

Investing forum

CTT PHARMACEUTICAL HOLDINGS, INC. Reports